Clinical trials
-
HPV Oral Infection -
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology driven by ongoing viral replication. This trial will evaluate S-217622 (ensitrelvir), an鈥�
- Investigator
- Nicole M Iovine
- Ages
- 18 Years - N/A
- Sexes
- All
-
JXR MEDI ASHB TILIA The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.
- Ages
- 18 Years - N/A
- Sexes
- All
-
REGEN-006 The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with鈥�
- Investigator
- Mark S Segal
- Ages
- 30 Years - 80 Years
- Sexes
- All
-
Intraosseous PJI- OrthoCarolina Purpose of Study: In order to improve upon the variable results seen in irrigation and debridement for periprosthetic infection, we ask if the use of intraosseous regional administration of antibiotics at the time of irrigation and debridement will鈥�
- Investigator
- Hernan A Prieto
- Ages
- 18 Years - N/A
- Sexes
- All
-
DIFI This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a鈥�
- Investigator
- Johan Nordenstam
- Ages
- 18 Years - N/A
- Sexes
- Female
-
Efficacy and Safety of the HAV W/AVF in Female Patients With End-Stage Renal Disease The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months in patients with end-stage renal disease (ESRD)鈥�
- Investigator
- Samir K Shah
- Ages
- 18 Years - N/A
- Sexes
- Female